Morse Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$3.15M |
| 2 |
Astera Labs
ALAB
|
+$2.89M |
| 3 |
Goldman Sachs
GS
|
+$2.72M |
| 4 |
Vistra
VST
|
+$2.04M |
| 5 |
Dell
DELL
|
+$1.54M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.45M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$4.97M |
| 3 |
Onto Innovation
ONTO
|
+$2.67M |
| 4 |
Pfizer
PFE
|
+$2.48M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$2.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.69% |
| 2 | Consumer Discretionary | 13.68% |
| 3 | Financials | 10.74% |
| 4 | Healthcare | 10.57% |
| 5 | Communication Services | 9.64% |
Similar funds
Morse Asset Management's Q4 2024 Portfolio in Review
As of Q4 2024, Morse Asset Management held 383 positions worth $438M, down 5.5% from $463M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Morse Asset Management withdrew a net $29.9M in Q4 2024, closing 53 positions and reducing 105 holdings. Its most notable exit was Alpha Architect 1-3 Month Box ETF, an estimated $2.07M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Morse Asset Management opened a new position in Emergent Biosolutions worth $1.52M.
- Morse Asset Management's largest Q4 2024 buy was Emergent Biosolutions: 158,819 shares worth $1.52M.
- Morse Asset Management added most to Bristol-Myers Squibb in Q4 2024, an estimated $3.15M increase.
- Morse Asset Management's biggest Q4 2024 reduction was Microsoft, cutting an estimated $8.45M.
- Morse Asset Management fully exited Alpha Architect 1-3 Month Box ETF in Q4 2024, selling an estimated $2.07M.
- Morse Asset Management's ten largest holdings make up 36% of its $438M portfolio in Q4 2024.
- Morse Asset Management opened 41 new positions and closed 53 in Q4 2024.
- Morse Asset Management's portfolio value fell 5.5% quarter-over-quarter to $438M.
Based on Morse Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.